Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.30 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19983792 | 0.74 | — | — | |
| SCHEMBL19973058 | 0.71 | ALDH1A1 (0.31) | KCNA3OPRM1MEN1KMT2A | |
| SCHEMBL31695088 | 0.68 | CYP2C19 (0.39) | OPRM1MEN1KMT2A | |
| SCHEMBL5180173 | 0.68 | CYP2C19 (0.39) | OPRM1MEN1KMT2A | |
| SCHEMBL25619136 | 0.67 | CYP2C19 (0.36) | MEN1KMT2A | |
| SCHEMBL1137710 | 0.67 | CYP2C19 (0.36) | MEN1KMT2A | |
| SCHEMBL7624802 | 0.66 | CYP2C19 (0.35) | MEN1KMT2A | |
| SCHEMBL19973111 | 0.65 | — | — | |
| SCHEMBL20980165 | 0.65 | POLB (0.41) | OPRM1MEN1KMT2ANR1H2NR1H3 | |
| SCHEMBL20980138 | 0.65 | ATM (0.40) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240376041-A1 | METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2024-11-14 | — | — | US | disclosed |
| US-12098115-B2 | Methods and compositions for terpenoid synthesis | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2024-09-24 | — | — | US | disclosed |
| US-11952327-B2 | Methods and compositions for terpenoid synthesis | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2024-04-09 | — | — | US | disclosed |
| US-20240025843-A1 | METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2024-01-25 | — | — | US | disclosed |
| US-20190270700-A1 | METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS | UNIV FLORIDA (US) | 2019-09-05 | — | — | US | disclosed |
| WO-2018053322-A1 | METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2018-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11952327-B2 | Methods and compositions for terpenoid synthesis | SQLE, GGPS1, LSS | KCNA3 1309/4885OPRM1 2046/4885MEN1 2816/4885 |
| US-20240376041-A1 | METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS | SQLE, GGPS1, LSS | KCNA3 1309/4885OPRM1 2046/4885MEN1 2816/4885 |
| US-20240025843-A1 | METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS | SQLE, GGPS1, LSS | KCNA3 1309/4885OPRM1 2046/4885MEN1 2816/4885 |
| US-12098115-B2 | Methods and compositions for terpenoid synthesis | SQLE, GGPS1, LSS | KCNA3 1309/4885OPRM1 2046/4885MEN1 2816/4885 |
| US-20190270700-A1 | METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS | SQLE, GGPS1, LSS | KCNA3 1267/4885OPRM1 2195/4885MEN1 2880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.